IMMUNO-INFLAMATORY RESPONSE IN ISCHEMIC HEART DISEASE
https://doi.org/10.20996/1819-6446-2007-3-2-16-19
Abstract
Aim. To estimate the role of immuno-inflammatory response in developing of angina pectoris in patients with ischemic heart disease (IHD).
Material and methods: The study included 83 patients with IHD and angina pectoris of functional class (FC) II (30 patients), III (27 patients) and IV (26 patients). The control group included 25 healthy persons. Bicycle burden test, daily ECG monitoring and echocardiography were used to verify of IHD. Levels of С-reactive protein (CRP), pro-inflammatory cytokines: interleukin-1β, interleukin-6 (IL-1β, IL-6) and tumor necrosis factor alpha (TNF-α) were examined by immunoenzyme method. Levels of anti-inflammatory cytokines were also defined: interleukin-4 and interleukin-10 (IL-4, IL-10).
Results. Increased levels of IL-4 and IL-10 with normal CRP and pro-inflammatory cytokine levels were observed in patients with angina of FC-II. Angina of FC-III was associated with a moderate increase in CRP level and normal levels of IL-4 and IL-10. The maximal levels of CRP and pro-inflammatory cytokines as well as minimal levels of anti-inflammatory cytokines were observed in patients with FC-IV angina pectoris.
Conclusion. The immuno-inflammatory response depends on angina pectoris severity in patients with IHD. Severe angina pectoris is accompanied by raised expression of pro-inflammatory cytokines and deficiency of anti-inflammatory cytokines.
About the Authors
N. E. Zakirova
Bashkir State Medical University of Roszdrav, Ufa
Russian Federation
Russian Federation
N. Kh. Khafizova
Bashkir State Medical University of Roszdrav, Ufa
Russian Federation
Russian Federation
I. M. Karamova
Bashkir State Medical University of Roszdrav, Ufa
Russian Federation
Russian Federation
A. N. Zakirova
Bashkir State Medical University of Roszdrav, Ufa
Russian Federation
Russian Federation
R. G. Oganov
State Research centre of preventative medicine of Roszdrav, Moscow
Russian Federation
Russian Federation
References
1. Оганов Р.Г., Масленникова Г.Я. Профилактика сердечно-сосудистых заболеваний – реальный путь улучшения демографической ситуации в России. Кардиология 2007;(1):4-7.
2. Насонов Е.Л. Иммунологические маркеры атеросклероза. Тер арх 2002;(5):80-5.
3. Ross R. Atherosclerosis – an inflammatory disease. N Engl J Med 1999;340:115-26.
4. Harrison D.G. Endothelial function and oxidants stress. Clin Cardiol 1997;20(11 Suppl 2):II-11-7.
5. Насонов Е.Л. Маркеры воспаления и атеросклероз: значение С- реактивного белка. Кардиология 1999;39(2):81-5.
6. Hansson G.K. Cell-mediated immunity in atherosclerosis. Curr Opin Lipidol 1997;8(5):301-11.
7. Bachetti J., Ferrari R. The dynamic balance between heart function and immune activation. Eur Heart J. 1998;19(5):681-2.
8. Ridker P., Hennekens C., Buring J.E., Ribai N. C-reactive protein and other marker of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000;342:836-43.
9. Steel D.M. Whitehead A.S. The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol Today 1994;15(2):81-8.
10. Нагорнев В.А., Зота Е.Г. Цитокины, иммунное воспаление и атерогенез. Усп соврем биол 1996;116:320-31.
11. Ребров А.П., Воскобой И.В. Роль воспалительных и инфекционных факторов в развитии атеросклероза. Тер арх 2004;76(1):78- 82.
12. Volpato S., Guralnik J.M., Ferrucci L. et al. Cardiovascular disease, interleukin-6, and risk of mortality in older women: the women's health and aging study. Circulation 2001;103:947-53.
13. Симбирцев А.С. Биология семейства интерлейкина-1 человека. Иммунология 1998;(3):9-17.
14. Волков В.И., Серик С.А. Провоспалительные цитокины и растворимая молекула межклеточной адгезии при ишемической болезни сердца. Кардиология 2002;42(9):12-6.
15. Hasdai D, Scheinowitz M, Leibovitz E, et al. Increased serum concentrations of interleukin-1 beta in patients with coronary artery disease. Heart 1996;76:24-8.
16. Ярилин А.А. Основы иммунологии. М.: Медицина, 1999.
17. Yokoyama T., Nakano M., Bednereruk J.L. et al. Tumor necrosis factor-alpha provokes a hypertrophic growth response in adult cardiac myocytes. Circulation 1997;95:1247-52.
18. Mallat Z., Bernarol S., Durier M. et al. Protective role of interleukin- 10 in atherosclerosis. Circ Res 1999;85:e17-24.
19. Pindersky Oslund L.J., Hedrick C.C., Olvera T., et al. Interleukin-10 blocks atherosclerotic events in vitro and in vivo. Atheroscler Thromb Vasc Biol 1999;19:2847-53.
20. Закирова А.Н., Мухаметрахимова А.Р., Закирова Н.Э. Состояние систолической функции левого желудочка и активность провоспалительных цитокинов при остром инфаркте миокарда. Журнал Сердечная недостаточность 2005;6(4):162-5.
21. Kelly K.A., Smith T.W. Cytokines and contractive function. Circulation 1997;95:778-81.
Review
For citations:
Zakirova N.E., Khafizova N.Kh., Karamova I.M., Zakirova A.N., Oganov R.G. IMMUNO-INFLAMATORY RESPONSE IN ISCHEMIC HEART DISEASE. Rational Pharmacotherapy in Cardiology. 2007;3(2):16-19. (In Russ.) https://doi.org/10.20996/1819-6446-2007-3-2-16-19
Views:
1734
Email this article 